483
Everest Life Sciences LLCFDA 483 - Everest Life Sciences LLC - April 23, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Everest Life Sciences LLC in Plainsboro, NJ, a finished dose and API manufacturer, revealed significant deficiencies across multiple areas. The firm failed to establish adequate controls for process validation, equipment qualification, cleaning validation, laboratory testing, and computer systems. These issues indicate a lack of adherence to cGMP standards, potentially impacting drug product quality and purity.
Open in Dashboard
ID · 072cf8e7-0149-48bc-b870-b6a1b67e606c